类风湿关节炎患者新发心力衰竭及心力衰竭亚型的风险
在两家大型学术中心同意广泛研究的参与者中,识别出1445例类风湿关节炎(RA)患者和4335例匹配的非RA对照者,按接近心衰发病日的射血分数对心衰亚型分类。调整心血管疾病危险因素后,RA患者新发心衰的风险比为1.79(95%CI 1.38-2.32),射血分数保留的心衰(HFpEF)风险比为1.99(95%CI 1.43-2.77),射血分数降低的心衰(HFrEF)风险比为1.45(95%CI 0.81-2.60),无统计学差异。
要点
- RA患者新发心衰风险较非RA对照升高,HR 1.79(95%CI 1.38-2.32)。
- HFpEF是两组最常见心衰亚型,RA组65% vs 非RA组59%。
- RA组HFpEF风险升高(HR 1.99,95%CI 1.43-2.77),HFrEF无统计学差异(HR 1.45,95%CI 0.81-2.60)。
核心结论
- 调整已确立的心血管疾病危险因素后,RA与新发心衰总体发生率升高相关,该风险升高由HFpEF驱动,支持炎症在HFpEF中起作用,并提示有机会处理RA中的这一超额风险。
研究设计与样本
- 在两家大型学术中心同意广泛研究的参与者中识别RA患者并匹配非RA对照者,按接近心衰发病日的射血分数对新发心衰及心衰亚型分类,使用Cox比例风险模型估计风险比。
主要发现
- 共纳入1445例RA患者和4335例匹配非RA对照者,平均年龄分别为51.4岁和51.7岁,女性占78.7%。
- HFpEF是两组最常见的心衰亚型,RA组为65%,非RA组为59%。
- 调整心血管疾病危险因素后,RA患者新发心衰的HR为1.79(95%CI 1.38-2.32)。
- RA患者HFpEF发生率更高,HR为1.99(95%CI 1.43-2.77)。
- HFrEF发生率无统计学差异,HR为1.45(95%CI 0.81-2.60)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with rheumatoid arthritis (RA) are at increased risk of cardiovascular disease (CVD) including heart failure (HF). However, little is known regarding the relative risks of HF subtypes such as HF with preserved ejection fraction (HFpEF) or reduced ejection fraction (HFrEF) in RA compared with non-RA. METHODS: We identified patients with RA and matched non-RA comparators among participants consenting to broad research from two large academic centers. We identified incident HF and categorized HF subtypes based on EF closest to the HF incident date. Covariates included age, sex, and established CVD risk factors. Cox proportional hazards models were used to estimate the hazard ratios (HRs) for incident HF and HF subtypes. RESULTS: We studied 1,445 patients with RA and 4,335 matched non-RA comparators (mean age 51.4 and 51.7 years, respectively; 78.7% female). HFpEF was the most common HF subtype in both groups (65% in RA vs 59% in non-RA). Patients with RA had an HR of 1.79 (95% confidence interval [CI] 1.38-2.32) for incident HF compared with those without RA after adjusting for CVD risk factors. Patients with RA had a higher rate of HFpEF (HR 1.99, 95% CI 1.43-2.77), but there was no statistical difference in the HFrEF rate (HR 1.45, 95% CI 0.81-2.60). CONCLUSION: RA was associated with a higher rate of HF overall compared with non-RA, even after adjustment for established CVD risk factors. The elevated risk was driven by HFpEF, supporting a role for inflammation in HFpEF and highlighting potential opportunities to address this excess risk in RA.
引用
- Kawano Y, Weber BN, Weisenfeld D, et al. Risk of Incident Heart Failure and Heart Failure Subtypes in Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2025. PMID: 39651569. doi:10.1002/acr.25481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。